GLP1R and type 2 diabetes mellitus: Current treatments of type 2 diabetes include injection of insulin or peptide agonists of glucagon-like peptide-1 receptor (GLP-1R) that provoke the synthesis and release of insulin (Gutniak et al., 1992 ▸).